J&J dives deep­er in­to bis­pecifics; Spring­Works an­nounces re­search deal over Stan­ford pro­fes­sor's work

Mass­a­chu­setts biotech F-Star en­tered a li­cens­ing and col­lab­o­ra­tion agree­ment with J&J in a deal po­ten­tial­ly worth $1.35 bil­lion in mile­stones.

In ex­change for $17.5 mil­lion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER